A Pharmacokinetic Comparability Study of a Commercial Supply of Eptinezumab

Trial Profile

A Pharmacokinetic Comparability Study of a Commercial Supply of Eptinezumab

Planning
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2018

At a glance

  • Drugs Eptinezumab (Primary)
  • Indications Migraine
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 Mar 2018 According to an Alder BioPharmaceuticals media release, this study is anticipated to complete in in the second half of 2018.
    • 06 Mar 2018 New trial record
    • 26 Feb 2018 According to an Alder BioPharmaceuticals media release, the company expects to initiate this trial in 2H 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top